Skip to main content

Red Light Therapy Market Forecast Report 2023-2032 by Emergen Research

Robust growth trend is expected to continue as more consumers and healthcare professionals recognize the therapeutic potential of red light therapy.

Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) — The global Red Light Therapy (RLT) market is expected to experience consistent revenue growth during the forecast period.The rise in market revenue can be attributed to the growing prevalence of chronic diseases worldwide, including fibromyalgia and arthritis. Fibromyalgia affects 2-4% of the population, with a higher incidence in women, according to the American College of Rheumatology. Osteoarthritis cases increased by 113% since 1990, reaching 528 million sufferers globally in 2019, as reported by the World Health Organization.

Red Light Therapy, or RLT, is emerging as a promising treatment for these chronic conditions. It appears to alleviate symptoms associated with fibromyalgia by promoting blood vessel dilation and angiogenesis, addressing issues related to poor circulation. Additionally, studies suggest that RLT can help reduce pain and inflammation in arthritis patients by stimulating cellular mitochondria to produce more Adenosine Triphosphate (ATP), aiding in pain relief and tissue regeneration.

Download Free Sample Report of Global Red Light Therapy Market @ https://www.emergenresearch.com/request-sample/2435

Growing awareness of the health benefits of RLT is another driving factor behind market growth. RLT has shown promise in wound healing, cancer treatment side effects, hair growth, carpal tunnel syndrome, myopia, psoriasis, burn scars, neuropathic pain, cognitive enhancement, and skin appearance. It has also gained popularity for its skin-related applications, activating collagen production to reduce wrinkles and treating acne.

However, one significant factor hindering market growth is the lack of insurance coverage. RLT sessions typically cost between USD 25 and USD 200, with costs varying based on the location and type of service. Furthermore, RLT equipment for home use ranges from USD 149 to thousands of dollars, and it is generally not covered by health insurance policies.

A recent trend in the market is the increasing use of Light Emitting Diode (LED) light therapy for skin. Red LED light therapy enhances skin cell function, strengthens mitochondria, stimulates collagen production, reduces redness, and improves circulation, making it a popular choice for anti-aging skin care treatments.

In terms of applications, the skin conditions segment is expected to dominate the global RLT market during the forecast period. Numerous studies have shown the effectiveness of RLT in treating eczema and psoriasis by reducing inflammation and improving skin health. The joint pain and arthritis segment is also expected to grow rapidly, with RLT proving to be a valuable treatment option for arthritis, including osteoarthritis and rheumatoid arthritis.

Click to Purchase this Report at an Exclusively Discounted Rate @ https://www.emergenresearch.com/request-discount/2435

When it comes to end-use, medical clinics are projected to hold the largest share of revenue. While red light therapy is not yet widely accepted as mainstream science, more medical clinics are incorporating this technology into their services, making it available to patients. The home care segment is expected to experience rapid growth as more individuals adopt RLT for personal use.

Regionally, North America is expected to lead in market revenue share, driven by key market players introducing innovative RLT devices to promote healing and reduce inflammation. In Asia Pacific, a unique treatment for myopia developed in China is gaining global attention, and Europe is witnessing advances in R&D activities that highlight the potential of RLT for vision improvement.

Scope of Research

Report DetailsOutcome
Market size in 2022in USD Million
CAGR (2023–2032)in %
Revenue forecast to 2032in USD Million
Base year for estimation2022
Historical data2019–2021
Forecast period2023–2032
Quantitative unitsRevenue in USD Million and CAGR in % from 2023 to 2032.
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends.
Segments coveredProduct, application, end-use, and region.
Regional scopeNorth America; Europe; Asia Pacific; Latin America; Middle East & Africa.
Country scopeNorth America, Europe, Asia Pacific, LATAM, MEA
Key companies profiledWolf, Red Light Man, Trophy Skin, Beurer, Hebei Pu Kang Medical Equipment, Norlanya Technology, Proaller, Dyago, Wuhan Kolda Medical Technology, Jin Lai Te Medical, Joovv, Mito Red Light, Platinum Therapy Lights, RubyLux Lights, Celluma, LightStim, Red Therapy Company LLC, LightpathLED, LED Technologies, Revive Light Therapy
Customization scope10 hours of free customization and expert consultation.

Major Companies and Competitive Landscape

The global red light therapy market is consolidated, with few large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective red light therapy products. Some major players included in the global Red Light Therapy (RLT) market report are:

  • Wolf
  • Red Light Man
  • Trophy Skin
  • Beurer
  • Hebei Pu Kang Medical Equipment
  • Norlanya Technology
  • Proaller
  • Dyago
  • Wuhan Kolda Medical Technology
  • Jin Lai Te Medical
  • Joovv
  • Mito Red Light
  • Platinum Therapy Lights
  • RubyLux Lights
  • Celluma
  • LightStim
  • Red Therapy Company LLC
  • LightpathLED
  • LED Technologies
  • Revive Light Therapy

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2435

Strategic Development

  • On 22 June 2023The Lumaflex Body Pro will soon go on sale, according to the health tech company Lumaflex, which created the first portable, waterproof, flexible red light treatment device for muscle recovery, pain relief, wellness, and performance enhancement. Currently in production, this ground-breaking red light therapy device has received the U.S. Food and Drug Administration (FDA) Class 2 Certification. Early funders, as well as product ambassadors, soon had access to the device, which is assured to be delivered in August 2023. On the company’s Indiegogo campaign, supporters can sign up to acquire the Lumaflex Body Pro device for a USD 220 discount and receive additional special advantages.
  • On 14 October 2021, Lifepro, a market leader in wellness and recovery equipment, unveiled its Red Light Therapy (RLT) line, which aims to offer affordable access to non-invasive wellness services. Each product addresses a different area of the body to offer comprehensive support for a range of illnesses and health objectives. This series will expand the company’s wide range of cutting-edge massage guns, home exercise equipment, vibration plates, and massagers that are all intended to offer customers low-impact exercises that are both economical and of the highest quality.

For More Details On this Report @ https://www.emergenresearch.com/industry-report/red-light-therapy-market

For the purpose of this report, Emergen Research has segmented the global red light therapy market on the basis of product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million; 2019–2032)
    • Lightboxes
    • Floor and desk lamps
    • Handheld devices
    • Light visors
    • Dawn simulators
  • Application Outlook (Revenue, USD Million; 2019–2032)
    • Skin conditions (e.g., psoriasis, eczema, acne)
    • Joint pain and arthritis
    • Wound healing
    • Pain management
    • Anti-aging
    • Sports performance
    • Mood and sleep disorders
    • Other
  • End-Use Outlook (Revenue, USD Million; 2019–2032)
    • Medical clinics
    • Home care
    • Spas and salons
    • Other
  • Regional Outlook (Revenue, USD Million, 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. Spain
      5. BENELUX
      6. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Israel
      4. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Artificial Organs Market By Organ Type (Artificial Kidney, Liver, Heart, Lungs, Pancreas), By Usage (Implantable, Extracorporeal), By Material Type (Silicon, Plastic, Steel), Forecasts to 2027

Mammography System Market, By Product (Digital Mammography System, Analog Mammography System, and Others), By Modality, By Technology, By End-Use (Hospital, Ambulatory Surgical Centers, and Others), and By Region Forecast to 2032

Surgical Robotics Market By Types (Neurosurgery, Spinal surgery, ENT Surgery, Orthopedic Surgery, Robotic Radiosurgery System), By Applications (Pediatrics, Adults, Geriatrics), By End Use (Hospitals, Ambulatory Care Centers, Others), and Regions Forecasts to 2027

Point of Care Testing Market, By Product (Glucose Monitoring Products, Infectious Disease Testing Products), By Platform (Lateral Flow Assays, Immunoassay), By Mode of Purchase, By End-Use, and By Region Forecast to 2030

Smart Contact Lens Market By Type (Corrective, Therapeutic, Lifestyle), By Technology (Augmented Reality, Virtual Reality), By Application (Continuous Glucose Monitoring, Intraocular Pressure Monitoring, Others), By End-Use Industry, By Region Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.